{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:39:11Z","timestamp":1759228751738},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,27]],"date-time":"2014-02-27T00:00:00Z","timestamp":1393459200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0090338","type":"journal-article","created":{"date-parts":[[2014,2,27]],"date-time":"2014-02-27T23:23:32Z","timestamp":1393543412000},"page":"e90338","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Development of Pre-Clinical Models for Evaluating the Therapeutic Potential of Candidate siRNA Targeting STAT6"],"prefix":"10.1371","volume":"9","author":[{"given":"Gareth D.","family":"Healey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer A.","family":"Lockridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn","family":"Zinnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian M.","family":"Hopkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,2,27]]},"reference":[{"key":"ref1","first-page":"1297","article-title":"The dose-response characteristics of inhaled corticosteroids when used to treat asthma: an overview of Cochrane systematic reviews","volume":"100","author":"NP Adams","year":"2006"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/j.clinthera.2009.12.021","article-title":"Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone\/budesonide and formoterol\/salmeterol","volume":"31","author":"C Frois","year":"2009","journal-title":"Clin Ther"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.187.9.1537","article-title":"Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice","volume":"187","author":"T Akimoto","year":"1998","journal-title":"J Exp Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2174\/156652408785161032","article-title":"Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma","volume":"8","author":"DA Kuperman","year":"2008","journal-title":"Curr Mol Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.0105-2896.2004.00215.x","article-title":"Interleukin-13 in asthma pathogenesis","volume":"202","author":"M Wills-Karp","year":"2004","journal-title":"Immunol Rev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2174\/092986706777935140","article-title":"IL-13: a promising therapeutic target for bronchial asthma","volume":"13","author":"K Izuhara","year":"2006","journal-title":"Curr Med Chem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1517\/14728222.3.3.381","article-title":"Emerging therapeutic targets in allergy: IL-4R\u03b1 and Stat6","volume":"3","author":"K Izuhara","year":"1999","journal-title":"Emerging Therapeutic Targets"},{"key":"ref8","unstructured":"Oh CK, Geba GP and Molfino N (2010) Investigational therapeutics targeting the IL-4\/IL-13\/STAT6 pathway for the treatment of asthma. Eur Resp Rev 115."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.it.2007.04.007","article-title":"The epithelium takes centre stage in asthma and atopic dermatitis","volume":"28","author":"ST Holgate","year":"2007","journal-title":"Trends Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2007.08.004","article-title":"Beyond inflammation: epithelial cells are at the interface of innate and adaptive immunity","volume":"19","author":"A Kato","year":"2007","journal-title":"Current Opinion Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nm734","article-title":"Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma","volume":"8","author":"DA Kuperman","year":"2002","journal-title":"Nature Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2567.2008.02951.x","article-title":"RNA interference of STAT6 rapidly attenuates ongoing interleukin-13-mediated events in lung epithelial cells","volume":"127","author":"W Walker","year":"2009","journal-title":"Immunology"},{"key":"ref13","first-page":"401","article-title":"Identification of small interfering RNA targeting Signal Transducer and Activator of Transcription 6: Characterisation and selection of candidates for pre-clinical development","volume":"25","author":"GD Healey","year":"2010","journal-title":"J RNAi Gene Silencing"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jaci.2008.01.008","article-title":"Usefulness and optimization of mouse models of allergic airway disease","volume":"121","author":"FD Finkelman","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.drudis.2011.05.014","article-title":"Animal models of asthma: value, limitations and opportunities for alternative approaches","volume":"16","author":"AM Holmes","year":"2011","journal-title":"Drug Discovery Today"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1164\/rccm.2609002","article-title":"The mouse trap: it still yields few answers in asthma","volume":"174","author":"S Wenzel","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1513\/pats.200906-052DP","article-title":"United airways concept. What does it teach us about systemic inflammation in airways disease","volume":"6","author":"G-J Braunstahl","year":"2009","journal-title":"Proc Am Thorac Soc"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/MCP.0b013e32831de235","article-title":"Biomarkers in asthma","volume":"15","author":"A Murugan","year":"2009","journal-title":"Curr Opin Pulm Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaci.2010.06.047","article-title":"Allergic rhinitis and its impact on asthma (ARIA) guidelines. 2010 revision","volume":"126","author":"JL Brozek","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1067\/mai.2003.1592","article-title":"Rhinitis and asthma: evidence for respiratory system integration","volume":"111","author":"A Togias","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/jcmm.12014","article-title":"Evaluation of nasal epithelium sampling as a tool in the preclinical development of siRNA-based therapeutics for asthma","volume":"17","author":"GD Healey","year":"2013","journal-title":"J Cell Mol Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/138920011794520017","article-title":"Improving siRNA bio-distribution and minimizing side effects","volume":"12","author":"B Scaggiante","year":"2011","journal-title":"Curr Drug Metabol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"MW Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1023\/A:1015937605100","article-title":"Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa","volume":"7","author":"AR Hilgers","year":"1990","journal-title":"Pharm Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1023\/A:1016033702220","article-title":"The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarised efflux system","volume":"13","author":"MM Neurkar","year":"1996","journal-title":"Pharm, Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1093\/nar\/gni178","article-title":"Real-time quantification of microRNAs by stem-loop RT-PCR","volume":"33","author":"C Chen","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.4155\/fmc.11.149","article-title":"Drug permeability and transporter assays in Caco-2 and MDCK cell lines","volume":"16","author":"DA Volpe","year":"2011","journal-title":"Future Med Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/01926230600713475","article-title":"The nose revisited: a brief review of the comparative structure, function, and toxicologic pathology of the nasal epithelium","volume":"34","author":"JR Harkema","year":"2006","journal-title":"Toxicologic Pathol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4155\/tde.12.136","article-title":"siRNA therapeutics in the treatment of diseases","volume":"4","author":"S Bakhtiyari","year":"2013","journal-title":"Ther Deliv"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2741\/4087","article-title":"siRNA delivery: from basics to therapeutic applications","volume":"18","author":"T Musacchio","year":"2013","journal-title":"Front Biosci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.antiviral.2007.11.009","article-title":"Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV)","volume":"77","author":"J DeVincenzo","year":"2008","journal-title":"Antiviral Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e55168","DOI":"10.1371\/journal.pone.0055168","article-title":"A versatile method to design stem-loop primer-based quantitative PCR assays for detecting small regulatory RNA molecules","volume":"8","author":"Z Czimmerer","year":"2013","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/nbt1122","article-title":"Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs","volume":"23","author":"DV Morrissey","year":"2005","journal-title":"Nat Biotechnol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrm2085","article-title":"Illuminating the silence: understanding the structure and function of small RNAs","volume":"8","author":"TM Rana","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.addr.2009.04.006","article-title":"Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy","volume":"61","author":"Y Takahashi","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2742","article-title":"Knocking down barriers: advances in siRNA delivery","volume":"8","author":"KA Whitehead","year":"2009","journal-title":"Nat Rev Drug Discovery"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.addr.2009.05.002","article-title":"Small silencing RNAs: state-of-the-art","volume":"61","author":"D Grimm","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1208\/s12248-010-9210-4","article-title":"Delivery of siRNA therapeutics: barriers and carriers","volume":"12","author":"J Wang","year":"2010","journal-title":"AAPS J"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1038\/mtna.2012.57","article-title":"Pharmacological Characterization of a Novel ENaC\u03b1 siRNA (GSK2225745) With potential for the treatment of cystic fibrosis","volume":"2","author":"KL Clark","year":"2013","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1021\/ar200110p","article-title":"Nonviral pulmonary delivery of siRNA","volume":"45","author":"OM Merkel","year":"2012","journal-title":"Acc Chem Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1038\/mt.2011.206","article-title":"Uptake, efficacy, and systemic distribution of naked, inhaled short interfering RNA (siRNA) and locked nucleic acid (LNA) antisense","volume":"19","author":"SA Moschos","year":"2011","journal-title":"Mol Ther"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"7501","DOI":"10.4049\/jimmunol.0713433","article-title":"Small interfering RNA against transcription factor STAT6 inhibits allergic airway inflammation and hyperreactivity in mice","volume":"182","author":"Y Darcan-Nicolaisen","year":"2009","journal-title":"J Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jaci.2007.08.029","article-title":"Effect of chemically modified IL-13 short interfering RNA on development of airway hyperreseponsiveness in mice","volume":"121","author":"TN Lively","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0140-6736(10)60926-9","article-title":"Aerosol drug delivery: developments in device design and clinical use","volume":"377","author":"MB Dolovich","year":"2011","journal-title":"Lancet"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/thx.2008.112862","article-title":"Upper airway. 1. Allergic rhinitis and asthma: united disease through epithelial cells","volume":"64","author":"A Bourdin","year":"2009","journal-title":"Thorax"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1034\/j.1398-9995.2003.00105.x","article-title":"Links between rhinitis and asthma","volume":"58","author":"J Bousquet","year":"2003","journal-title":"Allergy"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1038\/mtna.2013.22","article-title":"Efficient biodistribution and gene silencing in the lung epithelium via intravenous liposomal delivery of siRNA","volume":"2","author":"J McCaskill","year":"2013","journal-title":"Mol Ther Nucleic Acids"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0090338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T01:45:19Z","timestamp":1565228719000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0090338"}},"subtitle":[],"editor":[{"given":"Ilya","family":"Ulasov","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,27]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0090338","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,27]]}}}